Drug Repurposing for Identification of S1P1 Agonists with Potential Application in Multiple Sclerosis Using In Silico Drug Design Approaches

Purpose: Drug repurposing is an approach successfully used for discovery of new therapeutic applications for the existing drugs. The current study was aimed to use the combination of in silico methods to identify FDA-approved drugs with possible S1P(1) agonistic activity useful in multiple sclerosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Alizadeh, Ali Akbar, Jafari, Behzad, Dastmalchi, Siavoush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871275/
https://www.ncbi.nlm.nih.gov/pubmed/36721815
http://dx.doi.org/10.34172/apb.2023.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871275/
https://www.ncbi.nlm.nih.gov/pubmed/36721815
http://dx.doi.org/10.34172/apb.2023.012

Ejemplares similares